Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The quest to understand and slow disease ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

(Science) A case report assessed the effect of continuous exposure to ofatumumab (Kesimpta) during pregnancy in a patient ...

The successful applicant will have completed a neurology (pediatric or adult) residency in good standing before starting the TSC fellowship. They should have an interest in pursuing an academic career ...

Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader ... and remain an important unmet ...

The findings are published in The Lancet Neurology. “Fatigue is one of the most common and debilitating symptoms of multiple sclerosis, yet there is still uncertainty about how available ...

The following is a summary of “A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple Sclerosis,” published in the November 2024 issue of Neurology by ...

For columnist Susan Payrovi, music and dance are key to connecting with others and living a joyful life with multiple ...

The following is a summary of “Assessing and tailoring predictive equations of VO2 max for women with multiple sclerosis with ...

In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly ...

Brier et al, Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients, Annals of Neurology (2024). DOI: 10.1002/ana.27027 ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...